RxNorm Semantic Concepts Index - 275
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "275".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 2750 | Complement component C1 | Designated preferred name (PT) | NO | |
| RxCUI: 2750 | Complement component C1 | Full form of descriptor (FN) | NO | |
| RxCUI: 2750022 | Domidine | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2750023 | detomidine hydrochloride 10 MG/ML [Domidine] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2750024 | Domidine Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2750025 | detomidine Injectable Solution [Domidine] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2750027 | Domidine 10 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2750027 | Domidine 10 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2750027 | Domidine 10 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2750028 | dihydroxyethyl stearyl glycinate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2750061 | capsaicin 0.025 % / menthol 1.5 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2750061 | capsaicin 0.025 % / menthol 1.5 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2750061 | capsaicin 0.025 % / menthol 1.5 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2750062 | pectin 5.07 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2750063 | kaolin 200 MG/mL / pectin 5.07 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2750063 | kaolin 200 MG/mL / pectin 5.07 MG/mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2750155 | daraxonrasib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2750156 | daraxonrasib 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2750157 | daraxonrasib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2750158 | daraxonrasib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2750159 | daraxonrasib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2750160 | daraxonrasib 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2750160 | daraxonrasib 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2750161 | Rasonque | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2750162 | daraxonrasib 100 MG [Rasonque] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2750163 | Rasonque Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2750164 | Rasonque Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2750165 | daraxonrasib Oral Tablet [Rasonque] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2750166 | RASONQUE 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2750166 | RASONQUE 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2750166 | RASONQUE 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2750167 | daraxonrasib 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2750168 | daraxonrasib 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2750168 | daraxonrasib 150 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2750169 | daraxonrasib 150 MG [Rasonque] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2750170 | RASONQUE 150 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2750170 | RASONQUE 150 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2750170 | RASONQUE 150 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2750171 | bictegravir 75 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2750172 | lenacapavir 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2750173 | bictegravir / lenacapavir | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2750174 | bictegravir / lenacapavir Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2750175 | bictegravir / lenacapavir Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2750176 | bictegravir / lenacapavir Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2750177 | bictegravir 75 MG / lenacapavir 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2750177 | bictegravir 75 MG / lenacapavir 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2750177 | bictegravir 75 MG / lenacapavir 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2750178 | Bixlenvo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2750179 | bictegravir 75 MG / lenacapavir 50 MG [Bixlenvo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2750180 | Bixlenvo Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2750181 | Bixlenvo Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2750182 | bictegravir / lenacapavir Oral Tablet [Bixlenvo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2750183 | Bixlenvo 75 MG / 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2750183 | Bixlenvo 75 MG / 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2750183 | Bixlenvo 75 MG / 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2750184 | tebipenem pivoxil hydrobromide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2750185 | tebipenem pivoxil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2750186 | tebipenem pivoxil 300 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2750187 | tebipenem pivoxil Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2750188 | tebipenem pivoxil Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2750189 | tebipenem pivoxil Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2750190 | tebipenem pivoxil 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2750190 | tebipenem pivoxil 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2750190 | tebipenem pivoxil 300 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2750191 | Utebzi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2750192 | tebipenem pivoxil 300 MG [Utebzi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2750193 | Utebzi Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2750194 | Utebzi Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2750195 | tebipenem pivoxil Oral Tablet [Utebzi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2750196 | Utebzi 300 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2750196 | Utebzi 300 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2750196 | Utebzi 300 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2750197 | clonidine hydrochloride 0.05 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2750197 | clonidine hydrochloride 0.05 MG/ML | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2750198 | cloNIDine hydrochloride 0.05 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2750198 | cloNIDine hydrochloride 0.05 MG/mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2750198 | cloNIDine hydrochloride 0.05 MG/mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2750199 | Qlonilik | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2750200 | clonidine hydrochloride 0.05 MG/ML [Qlonilik] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2750200 | clonidine hydrochloride 0.05 MG/ML [Qlonilik] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2750201 | Qlonilik Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2750202 | Qlonilik Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2750203 | clonidine Oral Solution [Qlonilik] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2750203 | clonidine Oral Solution [Qlonilik] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2750204 | clonidine hydrochloride Oral Solution [Qlonilik] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2750205 | Qlonilik 0.05 MG/mL Oral Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2750205 | Qlonilik 0.05 MG/mL Oral Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2750205 | Qlonilik 0.05 MG/mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2750205 | Qlonilik 0.05 MG/mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2750219 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 XFG (JN.1) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2750220 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 XFG (JN.1) 0.05 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2750223 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 XFG (JN.1) 0.2 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2750223 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 XFG (JN.1) 0.2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2750223 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 XFG (JN.1) 0.2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2750224 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 XFG (JN.1) 0.05 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2750225 | Mnexspike 2026-2027 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2750226 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 XFG (JN.1) 0.05 MG/ML [Mnexspike 2026-2027] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2750227 | Mnexspike 2026-2027 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2750228 | SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Prefilled Syringe [Mnexspike 2026-2027] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2750230 | mNEXSPIKE 2026-2027 vaccine, 0.2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2750230 | mNEXSPIKE 2026-2027 vaccine, 0.2 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2750230 | mNEXSPIKE 2026-2027 vaccine, 0.2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2750230 | mNEXSPIKE 2026-2027 vaccine, 0.2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2750231 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 XFG (JN.1) 0.05 MG/ML Prefilled Syringe [Mnexspike 2026-2027] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2750231 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1283 XFG (JN.1) 0.05 MG/ML Prefilled Syringe [Mnexspike 2026-2027] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2750232 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 XFG (JN.1) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2750233 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 XFG (JN.1) 0.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2750236 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 XFG (JN.1) 0.25 ML Prefilled Syringe, 6m through 11y | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2750236 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 XFG (JN.1) 0.25 ML Prefilled Syringe, 6m through 11y | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2750236 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 XFG (JN.1) 0.25 ML Prefilled Syringe, 6m through 11y | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2750237 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 XFG (JN.1) 0.1 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2750238 | Spikevax 2026-2027 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2750239 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 XFG (JN.1) 0.1 MG/ML [Spikevax 2026-2027] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2750240 | Spikevax 2026-2027 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2750241 | SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Prefilled Syringe [Spikevax 2026-2027] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2750243 | spikevax 2026-2027 vaccine, 0.25 ML Prefilled Syringe, 6m through 11y | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2750243 | spikevax 2026-2027 vaccine, 0.25 ML Prefilled Syringe, 6m through 11y | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2750243 | spikevax 2026-2027 vaccine, 0.25 ML Prefilled Syringe, 6m through 11y | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2750243 | spikevax 2026-2027 vaccine, 0.25 ML Prefilled Syringe, 6m through 11y | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2750244 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 XFG (JN.1) 0.1 MG/ML Prefilled Syringe [Spikevax 2026-2027] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2750244 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 XFG (JN.1) 0.1 MG/ML Prefilled Syringe [Spikevax 2026-2027] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2750245 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 XFG (JN.1) 0.5 ML Prefilled Syringe, 12y+ | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2750245 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 XFG (JN.1) 0.5 ML Prefilled Syringe, 12y+ | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2750245 | SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 XFG (JN.1) 0.5 ML Prefilled Syringe, 12y+ | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2750246 | spikevax 2026-2027 vaccine, 0.5 ML Prefilled Syringe, 12y+ | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2750246 | spikevax 2026-2027 vaccine, 0.5 ML Prefilled Syringe, 12y+ | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2750246 | spikevax 2026-2027 vaccine, 0.5 ML Prefilled Syringe, 12y+ | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2750246 | spikevax 2026-2027 vaccine, 0.5 ML Prefilled Syringe, 12y+ | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2750247 | Product containing sonrotoclax (medicinal product) | Full form of descriptor (FN) | YES | |
| RxCUI: 2750247 | Product containing sonrotoclax (medicinal product) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2750247 | Product containing sonrotoclax (medicinal product) | Designated preferred name (PT) | YES | |
| RxCUI: 2750247 | Product containing sonrotoclax (medicinal product) | Full form of descriptor (FN) | YES | |
| RxCUI: 2750247 | Product containing sonrotoclax (medicinal product) | Designated preferred name (PT) | YES | |
| RxCUI: 2750248 | sonrotoclax 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2750249 | sonrotoclax Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2750250 | sonrotoclax Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2750251 | sonrotoclax Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2750252 | sonrotoclax 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2750252 | sonrotoclax 1 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2750253 | Beqalzi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2750254 | sonrotoclax 1 MG [Beqalzi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2750255 | Beqalzi Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2750256 | Beqalzi Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2750257 | sonrotoclax Oral Tablet [Beqalzi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2750258 | BEQALZI 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2750258 | BEQALZI 1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2750258 | BEQALZI 1 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2750259 | sonrotoclax 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2750260 | sonrotoclax 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2750260 | sonrotoclax 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2750261 | sonrotoclax 5 MG [Beqalzi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2750262 | BEQALZI 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2750262 | BEQALZI 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2750262 | BEQALZI 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2750263 | sonrotoclax 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2750264 | sonrotoclax 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2750264 | sonrotoclax 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2750265 | sonrotoclax 20 MG [Beqalzi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2750266 | BEQALZI 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2750266 | BEQALZI 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2750266 | BEQALZI 20 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2750267 | sonrotoclax 80 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2750268 | sonrotoclax 80 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2750268 | sonrotoclax 80 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2750269 | sonrotoclax 80 MG [Beqalzi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2750270 | BEQALZI 80 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2750270 | BEQALZI 80 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2750270 | BEQALZI 80 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 27505 | Inderide | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2751336 | sonrotoclax starter pack 1 MG (11), 5 MG (11), 20 MG (11), 80 MG (11) Oral Tablet 4 Week Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2751336 | sonrotoclax starter pack 1 MG (11), 5 MG (11), 20 MG (11), 80 MG (11) Oral Tablet 4 Week Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751336 | sonrotoclax starter pack 1 MG (11), 5 MG (11), 20 MG (11), 80 MG (11) Oral Tablet 4 Week Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751337 | BEQALZI Starter Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2751337 | BEQALZI Starter Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751337 | BEQALZI Starter Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751338 | benzalkonium chloride 0.02 % / benzocaine 20 % / menthol 0.26 % / zinc chloride 0.15 % Oral Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2751338 | benzalkonium chloride 0.02 % / benzocaine 20 % / menthol 0.26 % / zinc chloride 0.15 % Oral Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2751338 | benzalkonium chloride 0.02 % / benzocaine 20 % / menthol 0.26 % / zinc chloride 0.15 % Oral Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2751339 | menthol 0.0076 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2751340 | benzalkonium chloride 0.02 % / benzocaine 20 % / menthol 0.76 % / zinc chloride 0.15 % Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2751340 | benzalkonium chloride 0.02 % / benzocaine 20 % / menthol 0.76 % / zinc chloride 0.15 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2751340 | benzalkonium chloride 0.02 % / benzocaine 20 % / menthol 0.76 % / zinc chloride 0.15 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2751485 | brepocitinib tosylate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2751486 | brepocitinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2751487 | silicified microcrystalline cellulose (65M) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2751494 | ethanol 0.856 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2751495 | ethanol 85.6 % Topical Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2751495 | ethanol 85.6 % Topical Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2751495 | ethanol 85.6 % Topical Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2751537 | brepocitinib 30 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2751538 | brepocitinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2751539 | brepocitinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2751540 | brepocitinib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2751541 | brepocitinib 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751541 | brepocitinib 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751541 | brepocitinib 30 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2751542 | Lisraya | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2751543 | brepocitinib 30 MG [Lisraya] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2751544 | Lisraya Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2751545 | Lisraya Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2751546 | brepocitinib Oral Tablet [Lisraya] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2751547 | LISRAYA 30 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2751547 | LISRAYA 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751547 | LISRAYA 30 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751547 | LISRAYA 30 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751551 | ketoconazole 1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2751551 | ketoconazole 1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2751551 | ketoconazole 1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2751560 | testosterone undecanoate 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2751561 | testosterone undecanoate 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751561 | testosterone undecanoate 50 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2751562 | testosterone undecanoate 50 MG [Kyzatrex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2751563 | KYZATREX 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751563 | KYZATREX 50 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751563 | KYZATREX 50 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2751593 | Omlyclo 300 MG in 2 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2751593 | Omlyclo 300 MG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751593 | Omlyclo 300 MG in 2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751593 | Omlyclo 300 MG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751595 | rusfertide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2751596 | rusfertide acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2751598 | rusfertide 9.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2751599 | rusfertide Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2751600 | rusfertide Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2751601 | rusfertide 9.5 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751601 | rusfertide 9.5 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751601 | rusfertide 9.5 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2751602 | Mimrylo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2751603 | rusfertide 9.5 MG [Mimrylo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2751604 | Mimrylo Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2751605 | rusfertide Injection [Mimrylo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2751606 | Mimrylo 9.5 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751606 | Mimrylo 9.5 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751606 | Mimrylo 9.5 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2751607 | rusfertide 19 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2751608 | rusfertide 19 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751608 | rusfertide 19 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751608 | rusfertide 19 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2751609 | rusfertide 19 MG [Mimrylo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2751610 | Mimrylo 19 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751610 | Mimrylo 19 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751610 | Mimrylo 19 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2751611 | rusfertide 28 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2751612 | rusfertide 28 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751612 | rusfertide 28 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751612 | rusfertide 28 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2751613 | rusfertide 28 MG [Mimrylo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2751614 | Mimrylo 28 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751614 | Mimrylo 28 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751614 | Mimrylo 28 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2751615 | rusfertide 41 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2751616 | rusfertide 41 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751616 | rusfertide 41 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751616 | rusfertide 41 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2751617 | rusfertide 41 MG [Mimrylo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2751618 | Mimrylo 41 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751618 | Mimrylo 41 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751618 | Mimrylo 41 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2751619 | rusfertide 54 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2751620 | rusfertide 54 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751620 | rusfertide 54 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751620 | rusfertide 54 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2751621 | rusfertide 54 MG [Mimrylo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2751622 | Mimrylo 54 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751622 | Mimrylo 54 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751622 | Mimrylo 54 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2751623 | isosteareth-10 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2751624 | praziquantel 18.2 MG / pyrantel 72.6 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2751624 | praziquantel 18.2 MG / pyrantel 72.6 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2751624 | praziquantel 18.2 MG / pyrantel 72.6 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2751658 | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2928 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2751659 | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2928 0.01 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2751662 | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2928 0.5 ML Prefilled Syringe, 12y+ | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2751662 | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2928 0.5 ML Prefilled Syringe, 12y+ | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751662 | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2928 0.5 ML Prefilled Syringe, 12y+ | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751663 | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2928 0.01 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2751664 | Nuvaxovid 2026-2027 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2751665 | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2928 0.01 MG/ML [Nuvaxovid 2026-2027] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2751666 | Nuvaxovid 2026-2027 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2751667 | SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein Prefilled Syringe [Nuvaxovid 2026-2027] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2751669 | Nuvaxovid 2026-2027 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2751669 | Nuvaxovid 2026-2027 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751669 | Nuvaxovid 2026-2027 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751670 | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2928 0.01 MG/ML Prefilled Syringe [Nuvaxovid 2026-2027] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2751670 | SARS-CoV-2 (COVID-19) vaccine, protein NVX-CoV2928 0.01 MG/ML Prefilled Syringe [Nuvaxovid 2026-2027] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2751671 | lanosterol 2.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2751672 | N-acetylcarnosine 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2751673 | lanosterol / N-acetylcarnosine | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2751674 | lanosterol / N-acetylcarnosine Ophthalmic Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2751675 | lanosterol / N-acetylcarnosine Ophthalmic Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2751676 | lanosterol 0.25 % / N-acetylcarnosine 1 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2751676 | lanosterol 0.25 % / N-acetylcarnosine 1 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2751676 | lanosterol 0.25 % / N-acetylcarnosine 1 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2751677 | Lumenpro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2751678 | lanosterol 2.5 MG/ML / N-acetylcarnosine 10 MG/ML [Lumenpro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2751679 | Lumenpro Ophthalmic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2751680 | lanosterol / N-acetylcarnosine Ophthalmic Solution [Lumenpro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2751681 | LumenPRO 0.25 % / 1 % Ophthalmic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2751681 | LumenPRO 0.25 % / 1 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2751681 | LumenPRO 0.25 % / 1 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 27518 | indobufen | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 27518 | indobufen | Designated preferred name (PT) | NO | |
| RxCUI: 27518 | indobufen | Full form of descriptor (FN) | NO | |
| RxCUI: 2751840 | Heartarmor Plus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2751841 | ivermectin 0.136 MG / pyrantel 114 MG [Heartarmor Plus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2751842 | Heartarmor Plus Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2751843 | Heartarmor Plus Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2751844 | Heartarmor Plus Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2751845 | ivermectin / pyrantel Chewable Tablet [Heartarmor Plus] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2751846 | HeartArmor Plus 136 MCG / 114 MG for dogs (26-50 lbs.) Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2751846 | HeartArmor Plus 136 MCG / 114 MG for dogs (26-50 lbs.) Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2751846 | HeartArmor Plus 136 MCG / 114 MG for dogs (26-50 lbs.) Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2751847 | ivermectin 0.272 MG / pyrantel 227 MG [Heartarmor Plus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2751848 | HeartArmor Plus for Dogs 272 MCG / 227 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2751848 | HeartArmor Plus for Dogs 272 MCG / 227 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2751848 | HeartArmor Plus for Dogs 272 MCG / 227 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2751849 | ivermectin 0.068 MG / pyrantel 57 MG [Heartarmor Plus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2751850 | HeartArmor Plus 68 MCG / 57 MG for dogs (up to 25 lbs.) Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2751850 | HeartArmor Plus 68 MCG / 57 MG for dogs (up to 25 lbs.) Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2751850 | HeartArmor Plus 68 MCG / 57 MG for dogs (up to 25 lbs.) Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2751851 | trazodone hydrochloride 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2751851 | trazodone hydrochloride 25 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2751852 | traZODone hydrochloride 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751852 | traZODone hydrochloride 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2751852 | traZODone hydrochloride 25 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2751853 | trazodone hydrochloride 75 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2751853 | trazodone hydrochloride 75 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2751854 | traZODone hydrochloride 75 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751854 | traZODone hydrochloride 75 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2751854 | traZODone hydrochloride 75 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2751855 | vusolimogene oderparepvec | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2751856 | vusolimogene oderparepvec-wtpg | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2751857 | vusolimogene oderparepvec-wtpg 1000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2751858 | vusolimogene oderparepvec Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2751859 | vusolimogene oderparepvec Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2751862 | vusolimogene oderparepvec-wtpg 1,000,000 PFU in 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2751862 | vusolimogene oderparepvec-wtpg 1,000,000 PFU in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751862 | vusolimogene oderparepvec-wtpg 1,000,000 PFU in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751863 | vusolimogene oderparepvec-wtpg 1,000,000 UNT/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2751863 | vusolimogene oderparepvec-wtpg 1,000,000 UNT/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2751864 | Tudriqev | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2751865 | vusolimogene oderparepvec-wtpg 1000000 UNT/ML [Tudriqev] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2751866 | Tudriqev Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2751867 | vusolimogene oderparepvec Injection [Tudriqev] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2751869 | TUDRIQEV 1,000,000 PFU in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751869 | TUDRIQEV 1,000,000 PFU in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2751869 | TUDRIQEV 1,000,000 PFU in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751869 | TUDRIQEV 1,000,000 PFU in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751870 | Tudriqev 1,000,000 UNT/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2751870 | Tudriqev 1,000,000 UNT/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2751870 | Tudriqev 1,000,000 UNT/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2751871 | vusolimogene oderparepvec-wtpg 10000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2751872 | vusolimogene oderparepvec-wtpg 10,000,000 PFU per 1 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2751872 | vusolimogene oderparepvec-wtpg 10,000,000 PFU per 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751872 | vusolimogene oderparepvec-wtpg 10,000,000 PFU per 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751873 | vusolimogene oderparepvec-wtpg 10,000,000 UNT/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2751873 | vusolimogene oderparepvec-wtpg 10,000,000 UNT/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2751873 | vusolimogene oderparepvec-wtpg 10,000,000 UNT/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2751874 | vusolimogene oderparepvec-wtpg 10000000 UNT/ML [Tudriqev] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2751875 | TUDRIQEV 10,000,000 PFU in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751875 | TUDRIQEV 10,000,000 PFU in 1 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2751875 | TUDRIQEV 10,000,000 PFU in 1 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751875 | TUDRIQEV 10,000,000 PFU in 1 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751876 | Tudriqev 10,000,000 UNT/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2751876 | Tudriqev 10,000,000 UNT/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2751876 | Tudriqev 10,000,000 UNT/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2751877 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 XFG (JN.1) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2751878 | salicylic acid 6.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2751879 | salicylic acid 0.65 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2751879 | salicylic acid 0.65 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2751879 | salicylic acid 0.65 % Medicated Liquid Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2751880 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 XFG (JN.1) 0.0333 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2751883 | SARS-CoV-2 (COVID-19) vaccine 2026-2027, mRNA-BNT162b2 XFG (JN.1) 0.3 ML Injection, 5y to < 12y | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2751883 | SARS-CoV-2 (COVID-19) vaccine 2026-2027, mRNA-BNT162b2 XFG (JN.1) 0.3 ML Injection, 5y to < 12y | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751883 | SARS-CoV-2 (COVID-19) vaccine 2026-2027, mRNA-BNT162b2 XFG (JN.1) 0.3 ML Injection, 5y to < 12y | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751884 | SARS-CoV-2 (COVID-19) vaccine 2026-2027, mRNA-BNT162b2 XFG (JN.1) Injection, 5y to < 12y | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2751884 | SARS-CoV-2 (COVID-19) vaccine 2026-2027, mRNA-BNT162b2 XFG (JN.1) Injection, 5y to < 12y | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2751885 | Comirnaty 2026-2027 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2751886 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 XFG (JN.1) 0.0333 MG/ML [Comirnaty 2026-2027] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2751887 | Comirnaty 2026-2027 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2751888 | SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Injection [Comirnaty 2026-2027] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2751890 | COMIRNATY 2026-2027 vaccine, 0.3 ML Injection, 5y to < 12y | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751890 | COMIRNATY 2026-2027 vaccine, 0.3 ML Injection, 5y to < 12y | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2751890 | COMIRNATY 2026-2027 vaccine, 0.3 ML Injection, 5y to < 12y | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751890 | COMIRNATY 2026-2027 vaccine, 0.3 ML Injection, 5y to < 12y | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751891 | COMIRNATY 2026-2027 vaccine, Injection, 5y to < 12y | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2751891 | COMIRNATY 2026-2027 vaccine, Injection, 5y to < 12y | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2751891 | COMIRNATY 2026-2027 vaccine, Injection, 5y to < 12y | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2751892 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 XFG (JN.1) 0.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2751894 | SARS-CoV-2 (COVID-19) vaccine 2026-2027, mRNA-BNT162b2 XFG (JN.1) 0.3 ML Prefilled Syringe, 12y+ | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2751894 | SARS-CoV-2 (COVID-19) vaccine 2026-2027, mRNA-BNT162b2 XFG (JN.1) 0.3 ML Prefilled Syringe, 12y+ | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751894 | SARS-CoV-2 (COVID-19) vaccine 2026-2027, mRNA-BNT162b2 XFG (JN.1) 0.3 ML Prefilled Syringe, 12y+ | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751895 | SARS-CoV-2 (COVID-19) vaccine 2026-2027, mRNA-BNT162b2 XFG (JN.1) Prefilled Syringe, 12y+ | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2751895 | SARS-CoV-2 (COVID-19) vaccine 2026-2027, mRNA-BNT162b2 XFG (JN.1) Prefilled Syringe, 12y+ | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2751896 | SARS-CoV-2 (COVID-19) vaccine, mRNA-BNT162b2 XFG (JN.1) 0.1 MG/ML [Comirnaty 2026-2027] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2751897 | SARS-CoV-2 (COVID-19) vaccine, mRNA spike protein Prefilled Syringe [Comirnaty 2026-2027] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2751899 | COMIRNATY 2026-2027 vaccine, 0.3 ML Prefilled Syringe, 12y+ | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751899 | COMIRNATY 2026-2027 vaccine, 0.3 ML Prefilled Syringe, 12y+ | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2751899 | COMIRNATY 2026-2027 vaccine, 0.3 ML Prefilled Syringe, 12y+ | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2751899 | COMIRNATY 2026-2027 vaccine, 0.3 ML Prefilled Syringe, 12y+ | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2751900 | COMIRNATY 2026-2027 vaccine, Prefilled Syringe, 12y+ | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2751900 | COMIRNATY 2026-2027 vaccine, Prefilled Syringe, 12y+ | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2751900 | COMIRNATY 2026-2027 vaccine, Prefilled Syringe, 12y+ | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2752 | C1q - complement component 1q | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2752 | C1q - complement component 1q | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2752 | C1q - complement component 1q | Designated preferred name (PT) | NO | |
| RxCUI: 2752 | C1q - complement component 1q | Full form of descriptor (FN) | NO | |
| RxCUI: 27523 | Indole 2,3-dioxygenase | Designated preferred name (PT) | NO | |
| RxCUI: 27523 | Indole 2,3-dioxygenase | Full form of descriptor (FN) | NO | |
| RxCUI: 2752327 | rizatriptan 5 MG [Rizafilm] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2752328 | RizaFilm 5 MG Oral Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2752328 | RizaFilm 5 MG Oral Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2752328 | RizaFilm 5 MG Oral Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2752328 | RizaFilm 5 MG Oral Film | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2752379 | hydrolyzed sodium hyaluronate hexasaccharide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2752682 | camizestrant | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2752683 | camizestrant 75 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2752684 | camizestrant Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2752685 | camizestrant Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2752686 | camizestrant Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2752687 | camizestrant 75 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2752687 | camizestrant 75 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2752688 | Etcamah | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2752689 | camizestrant 75 MG [Etcamah] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2752690 | Etcamah Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2752691 | Etcamah Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2752692 | camizestrant Oral Tablet [Etcamah] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2752693 | ETCAMAH 75 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2752693 | ETCAMAH 75 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2752693 | ETCAMAH 75 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2752694 | 3-(4-isobutylphenyl)-2-methylpropanal | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2752695 | praziquantel 15.2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2752696 | praziquantel 15.2 MG / pyrantel 72.6 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2752696 | praziquantel 15.2 MG / pyrantel 72.6 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2752696 | praziquantel 15.2 MG / pyrantel 72.6 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2752697 | morphine sulfate 1 MG in 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2752697 | morphine sulfate 1 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2752697 | morphine sulfate 1 MG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2752697 | morphine sulfate 1 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2752709 | menthol 3 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2752709 | menthol 3 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2752709 | menthol 3 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 275276 | Maltogenic alpha-amylase | Designated preferred name (PT) | NO | |
| RxCUI: 275276 | Maltogenic alpha-amylase | Full form of descriptor (FN) | NO | |
| RxCUI: 275276 | Maltogenic alpha-amylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 275280 | (-)-limonene 3-hydroxylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 275280 | (-)-limonene 3-hydroxylase | Designated preferred name (PT) | NO | |
| RxCUI: 275280 | (-)-limonene 3-hydroxylase | Full form of descriptor (FN) | NO | |
| RxCUI: 275281 | (-)-limonene 6-hydroxylase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 275281 | (-)-limonene 6-hydroxylase | Designated preferred name (PT) | NO | |
| RxCUI: 275281 | (-)-limonene 6-hydroxylase | Full form of descriptor (FN) | NO | |
| RxCUI: 2753 | C1r - complement component 1r | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2753 | C1r - complement component 1r | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2753 | C1r - complement component 1r | Designated preferred name (PT) | NO | |
| RxCUI: 2753 | C1r - complement component 1r | Full form of descriptor (FN) | NO | |
| RxCUI: 2753000 | nilotinib d-tartrate 150 MG [Nilceya] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2753001 | Nilceya Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2753002 | Nilceya Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2753003 | nilotinib Oral Capsule [Nilceya] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2753005 | Nilceya 150 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2753005 | Nilceya 150 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2753005 | Nilceya 150 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2753006 | nilotinib d-tartrate 200 MG [Nilceya] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2753007 | Nilceya 200 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2753007 | Nilceya 200 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2753007 | Nilceya 200 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2753008 | nilotinib d-tartrate 50 MG [Nilceya] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2753009 | Nilceya 50 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2753009 | Nilceya 50 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2753009 | Nilceya 50 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2753012 | Moximax | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2753013 | moxidectin 5 MG/ML [Moximax] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2753014 | Moximax Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2753015 | moxidectin Topical Solution [Moximax] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2753016 | MOXIMAX Pour-On for Cattle 5 MG/ML Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2753016 | MOXIMAX Pour-On for Cattle 5 MG/ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2753016 | MOXIMAX Pour-On for Cattle 5 MG/ML Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2753029 | zilganersen sodium | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2753030 | zilganersen | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2753031 | zilganersen 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2753032 | zilganersen Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2753033 | zilganersen Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2753034 | zilganersen 56 MG in 2.8 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2753034 | zilganersen 56 MG in 2.8 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753034 | zilganersen 56 MG in 2.8 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753035 | zilganersen 20 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2753035 | zilganersen 20 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2753036 | Zanvastro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2753037 | zilganersen 20 MG/ML [Zanvastro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2753038 | Zanvastro Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2753039 | zilganersen Injection [Zanvastro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2753040 | Zanvastro 56 MG in 2.8 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2753040 | Zanvastro 56 MG in 2.8 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753040 | Zanvastro 56 MG in 2.8 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753041 | Zanvastro 20 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2753041 | Zanvastro 20 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2753041 | Zanvastro 20 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2753048 | ethanol 0.773 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2753049 | ethanol 77.3 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2753049 | ethanol 77.3 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2753049 | ethanol 77.3 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2753050 | alpha galactosidase A, human | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2753051 | Bacillus licheniformis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2753052 | bacteriophage LF82_P2 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2753053 | dipeptidyl peptidase 3 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2753054 | pancreatic alpha-amylase | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2753055 | Pectin methylesterase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2753055 | Pectin methylesterase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2753055 | Pectin methylesterase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2753055 | Pectin methylesterase | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2753055 | Pectin methylesterase | Designated preferred name (PT) | NO | |
| RxCUI: 2753055 | Pectin methylesterase | Full form of descriptor (FN) | NO | |
| RxCUI: 2753057 | Desmopressin acetate trihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2753057 | Desmopressin acetate trihydrate | Designated preferred name (PT) | YES | |
| RxCUI: 2753057 | Desmopressin acetate trihydrate | Full form of descriptor (FN) | YES | |
| RxCUI: 2753074 | potassium myristate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2753075 | thymol 0.00063 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2753076 | lidocaine / thymol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2753077 | lidocaine / thymol Otic Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2753078 | lidocaine / thymol Otic Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2753081 | lidocaine HCl 4 % / thymol 0.063 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2753081 | lidocaine HCl 4 % / thymol 0.063 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2753081 | lidocaine HCl 4 % / thymol 0.063 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2753082 | Bexlutry | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2753083 | lutetium Lu 177 dotatate 10 MCI/ML [Bexlutry] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2753084 | Bexlutry Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2753085 | dotatate Injection [Bexlutry] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2753087 | Bexlutry 370 MBq/mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753087 | Bexlutry 370 MBq/mL Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2753087 | Bexlutry 370 MBq/mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753087 | Bexlutry 370 MBq/mL Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753087 | Bexlutry 370 MBq/mL Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753088 | lutetium Lu 177 dotatate 10 MCI/ML Injection [Bexlutry] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2753088 | lutetium Lu 177 dotatate 10 MCI/ML Injection [Bexlutry] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2753162 | apitegromab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2753163 | apitegromab-mstn | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2753164 | apitegromab-mstn 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2753165 | apitegromab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2753166 | apitegromab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2753169 | apitegromab-mstn 150 MG in 3 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2753169 | apitegromab-mstn 150 MG in 3 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753169 | apitegromab-mstn 150 MG in 3 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753170 | apitegromab-mstn 50 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2753171 | Isembyld | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2753172 | apitegromab-mstn 50 MG/ML [Isembyld] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2753173 | Isembyld Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2753174 | apitegromab Injection [Isembyld] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2753176 | ISEMBYLD 150 MG in 3 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2753176 | ISEMBYLD 150 MG in 3 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753176 | ISEMBYLD 150 MG in 3 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753176 | ISEMBYLD 150 MG in 3 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753177 | apitegromab-mstn 50 MG/ML Injection [Isembyld] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2753177 | apitegromab-mstn 50 MG/ML Injection [Isembyld] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2753293 | lidocaine 80 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2753294 | lidocaine 8 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2753294 | lidocaine 8 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2753294 | lidocaine 8 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2753295 | pariglasgene brecaparvovec | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2753316 | pariglasgene brecaparvovec-opnr | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2753317 | pariglasgene brecaparvovec-opnr 30000000000000 VECTOR-GENOMES/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2753318 | pariglasgene brecaparvovec Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2753319 | pariglasgene brecaparvovec Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2753322 | pariglasgene brecaparvovec-opnr 30000000000000 VECTOR-GENOMES/ML in 2 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2753322 | pariglasgene brecaparvovec-opnr 30000000000000 VECTOR-GENOMES/ML in 2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753322 | pariglasgene brecaparvovec-opnr 30000000000000 VECTOR-GENOMES/ML in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753323 | pariglasgene brecaparvovec-opnr 30000000000000 VECTOR-GENOMES/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2753324 | Genglycos | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2753325 | pariglasgene brecaparvovec-opnr 30000000000000 VECTOR-GENOMES/ML [Genglycos] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2753326 | Genglycos Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2753327 | pariglasgene brecaparvovec Injection [Genglycos] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2753329 | genglycos 30000000000000 VECTOR-GENOMES/ML in 2 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2753329 | genglycos 30000000000000 VECTOR-GENOMES/ML in 2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753329 | genglycos 30000000000000 VECTOR-GENOMES/ML in 2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753330 | pariglasgene brecaparvovec-opnr 30000000000000 VECTOR-GENOMES/ML Injection [Genglycos] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2753330 | pariglasgene brecaparvovec-opnr 30000000000000 VECTOR-GENOMES/ML Injection [Genglycos] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2753331 | pariglasgene brecaparvovec-opnr Kit Patient Weight 15 - < 21 kg | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2753331 | pariglasgene brecaparvovec-opnr Kit Patient Weight 15 - < 21 kg | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753331 | pariglasgene brecaparvovec-opnr Kit Patient Weight 15 - < 21 kg | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753332 | GENGLYCOS Kit Patient Weight 15 - < 21 kg | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2753332 | GENGLYCOS Kit Patient Weight 15 - < 21 kg | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753332 | GENGLYCOS Kit Patient Weight 15 - < 21 kg | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753333 | pariglasgene brecaparvovec-opnr Kit Patient Weight 21 - < 27 kg | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2753333 | pariglasgene brecaparvovec-opnr Kit Patient Weight 21 - < 27 kg | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753333 | pariglasgene brecaparvovec-opnr Kit Patient Weight 21 - < 27 kg | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753334 | GENGLYCOS Kit Patient Weight 21 - < 27 kg | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2753334 | GENGLYCOS Kit Patient Weight 21 - < 27 kg | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753334 | GENGLYCOS Kit Patient Weight 21 - < 27 kg | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753335 | pariglasgene brecaparvovec-opnr Kit Patient Weight 27 - < 33 kg | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2753335 | pariglasgene brecaparvovec-opnr Kit Patient Weight 27 - < 33 kg | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753335 | pariglasgene brecaparvovec-opnr Kit Patient Weight 27 - < 33 kg | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753336 | GENGLYCOS Kit Patient Weight 27 - < 33 kg | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2753336 | GENGLYCOS Kit Patient Weight 27 - < 33 kg | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753336 | GENGLYCOS Kit Patient Weight 27 - < 33 kg | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753337 | pariglasgene brecaparvovec-opnr Kit Patient Weight 33 - < 39 kg | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2753337 | pariglasgene brecaparvovec-opnr Kit Patient Weight 33 - < 39 kg | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753337 | pariglasgene brecaparvovec-opnr Kit Patient Weight 33 - < 39 kg | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753338 | GENGLYCOS Kit Patient Weight 33 - < 39 kg | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2753338 | GENGLYCOS Kit Patient Weight 33 - < 39 kg | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753338 | GENGLYCOS Kit Patient Weight 33 - < 39 kg | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753339 | pariglasgene brecaparvovec-opnr Kit Patient Weight 39 - < 45 kg | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2753339 | pariglasgene brecaparvovec-opnr Kit Patient Weight 39 - < 45 kg | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753339 | pariglasgene brecaparvovec-opnr Kit Patient Weight 39 - < 45 kg | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753340 | GENGLYCOS Kit Patient Weight 39 - < 45 kg | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2753340 | GENGLYCOS Kit Patient Weight 39 - < 45 kg | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753340 | GENGLYCOS Kit Patient Weight 39 - < 45 kg | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753341 | pariglasgene brecaparvovec-opnr Kit Patient Weight 45 - < 51 kg | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2753341 | pariglasgene brecaparvovec-opnr Kit Patient Weight 45 - < 51 kg | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753341 | pariglasgene brecaparvovec-opnr Kit Patient Weight 45 - < 51 kg | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753342 | GENGLYCOS Kit Patient Weight 45 - < 51 kg | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2753342 | GENGLYCOS Kit Patient Weight 45 - < 51 kg | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753342 | GENGLYCOS Kit Patient Weight 45 - < 51 kg | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753343 | pariglasgene brecaparvovec-opnr Kit Patient Weight 51 - < 57 kg | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2753343 | pariglasgene brecaparvovec-opnr Kit Patient Weight 51 - < 57 kg | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753343 | pariglasgene brecaparvovec-opnr Kit Patient Weight 51 - < 57 kg | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753344 | GENGLYCOS Kit Patient Weight 51 - < 57 kg | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2753344 | GENGLYCOS Kit Patient Weight 51 - < 57 kg | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753344 | GENGLYCOS Kit Patient Weight 51 - < 57 kg | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753345 | pariglasgene brecaparvovec-opnr Kit Patient Weight 57 - < 63 kg | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2753345 | pariglasgene brecaparvovec-opnr Kit Patient Weight 57 - < 63 kg | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753345 | pariglasgene brecaparvovec-opnr Kit Patient Weight 57 - < 63 kg | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753346 | GENGLYCOS Kit Patient Weight 57 - < 63 kg | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2753346 | GENGLYCOS Kit Patient Weight 57 - < 63 kg | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753346 | GENGLYCOS Kit Patient Weight 57 - < 63 kg | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753347 | pariglasgene brecaparvovec-opnr Kit Patient Weight 63 - < 69 kg | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2753347 | pariglasgene brecaparvovec-opnr Kit Patient Weight 63 - < 69 kg | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753347 | pariglasgene brecaparvovec-opnr Kit Patient Weight 63 - < 69 kg | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753348 | GENGLYCOS Kit Patient Weight 63 - < 69 kg | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2753348 | GENGLYCOS Kit Patient Weight 63 - < 69 kg | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753348 | GENGLYCOS Kit Patient Weight 63 - < 69 kg | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753349 | pariglasgene brecaparvovec-opnr Kit Patient Weight 69 - < 75 kg | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2753349 | pariglasgene brecaparvovec-opnr Kit Patient Weight 69 - < 75 kg | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753349 | pariglasgene brecaparvovec-opnr Kit Patient Weight 69 - < 75 kg | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753350 | GENGLYCOS Kit Patient Weight 69 - < 75 kg | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2753350 | GENGLYCOS Kit Patient Weight 69 - < 75 kg | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753350 | GENGLYCOS Kit Patient Weight 69 - < 75 kg | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753351 | pariglasgene brecaparvovec-opnr Kit Patient Weight 75 - < 81 kg | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2753351 | pariglasgene brecaparvovec-opnr Kit Patient Weight 75 - < 81 kg | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753351 | pariglasgene brecaparvovec-opnr Kit Patient Weight 75 - < 81 kg | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753352 | GENGLYCOS Kit Patient Weight 75 - < 81 kg | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2753352 | GENGLYCOS Kit Patient Weight 75 - < 81 kg | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753352 | GENGLYCOS Kit Patient Weight 75 - < 81 kg | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753353 | pariglasgene brecaparvovec-opnr Kit Patient Weight 81 - < 87 kg | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2753353 | pariglasgene brecaparvovec-opnr Kit Patient Weight 81 - < 87 kg | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753353 | pariglasgene brecaparvovec-opnr Kit Patient Weight 81 - < 87 kg | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753354 | GENGLYCOS Kit Patient Weight 81 - < 87 kg | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2753354 | GENGLYCOS Kit Patient Weight 81 - < 87 kg | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753354 | GENGLYCOS Kit Patient Weight 81 - < 87 kg | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753355 | pariglasgene brecaparvovec-opnr Kit Patient Weight > 87 kg | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2753355 | pariglasgene brecaparvovec-opnr Kit Patient Weight > 87 kg | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753355 | pariglasgene brecaparvovec-opnr Kit Patient Weight > 87 kg | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753356 | GENGLYCOS Kit Patient Weight > 87 kg | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2753356 | GENGLYCOS Kit Patient Weight > 87 kg | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753356 | GENGLYCOS Kit Patient Weight > 87 kg | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753464 | Florfinasone | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2753465 | florfenicol 16.6 MG/ML / mometasone furoate 2.2 MG/ML / terbinafine 14.8 MG/ML [Florfinasone] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2753466 | Florfinasone Otic Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2753467 | florfenicol / mometasone / terbinafine Otic Solution [Florfinasone] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2753469 | Florfinasone 16.6 MG / 14.8 MG / 2.2 MG in 1 ML Otic Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2753469 | Florfinasone 16.6 MG / 14.8 MG / 2.2 MG in 1 ML Otic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2753469 | Florfinasone 16.6 MG / 14.8 MG / 2.2 MG in 1 ML Otic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2753470 | My After Plan | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2753471 | levonorgestrel 1.5 MG [My After Plan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2753472 | My After Plan Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2753473 | My After Plan Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2753474 | levonorgestrel Oral Tablet [My After Plan] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2753475 | My After Plan 1.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2753475 | My After Plan 1.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2753475 | My After Plan 1.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2753518 | diclofenac potassium 75 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753518 | diclofenac potassium 75 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753518 | diclofenac potassium 75 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753518 | diclofenac potassium 75 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2753519 | PEG-7 caprylic-capric glycerides | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2753575 | PPG-7 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2753594 | salicylic acid 40 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2753594 | salicylic acid 40 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2753594 | salicylic acid 40 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 27536 | N-(indole-3-acetyl)-L-lysine synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 27536 | N-(indole-3-acetyl)-L-lysine synthetase | Designated preferred name (PT) | NO | |
| RxCUI: 27536 | N-(indole-3-acetyl)-L-lysine synthetase | Full form of descriptor (FN) | NO | |
| RxCUI: 27536 | N-(indole-3-acetyl)-L-lysine synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2753780 | fenbendazole 200 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2753781 | fenbendazole 20 % Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2753781 | fenbendazole 20 % Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2753781 | fenbendazole 20 % Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2753782 | Lactiplantibacillus plantarum DSM 24730 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2753783 | Curcuma heyneana root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2753784 | carboxymethylcellulose sodium 0.5 % / glycerin 0.3 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2753784 | carboxymethylcellulose sodium 0.5 % / glycerin 0.3 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2753784 | carboxymethylcellulose sodium 0.5 % / glycerin 0.3 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2753785 | sulfur 0.099 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2753786 | sulfur 9.9 % Medicated Bar Soap | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2753786 | sulfur 9.9 % Medicated Bar Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2753786 | sulfur 9.9 % Medicated Bar Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2753787 | menthol 10.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2753787 | menthol 10.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2753787 | menthol 10.5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2753788 | camphor 2 % / menthol 2 % / methyl salicylate 10 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2753788 | camphor 2 % / menthol 2 % / methyl salicylate 10 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2753788 | camphor 2 % / menthol 2 % / methyl salicylate 10 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2753789 | minoxidil Shampoo Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2753790 | minoxidil Medicated Shampoo | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2753791 | minoxidil 5 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2753791 | minoxidil 5 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2753791 | minoxidil 5 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2753879 | hydrocortisone / menthol / miconazole | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2753880 | hydrocortisone / menthol / miconazole Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2753881 | hydrocortisone / menthol / miconazole Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2753884 | hydrocortisone 1 % / menthol 0.5 % / miconazole nitrate 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2753884 | hydrocortisone 1 % / menthol 0.5 % / miconazole nitrate 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2753884 | hydrocortisone 1 % / menthol 0.5 % / miconazole nitrate 2 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2753887 | leniolisib 50 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2753888 | leniolisib 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753888 | leniolisib 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753888 | leniolisib 50 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2753889 | leniolisib 50 MG [Joenja] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2753890 | Joenja 50 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753890 | Joenja 50 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753890 | Joenja 50 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2753891 | leniolisib 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2753892 | leniolisib 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753892 | leniolisib 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753892 | leniolisib 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2753893 | leniolisib 40 MG [Joenja] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2753894 | Joenja 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2753894 | Joenja 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2753894 | Joenja 40 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2754 | C1s - complement component 1s | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2754 | C1s - complement component 1s | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2754 | C1s - complement component 1s | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2754 | C1s - complement component 1s | Designated preferred name (PT) | NO | |
| RxCUI: 2754 | C1s - complement component 1s | Full form of descriptor (FN) | NO | |
| RxCUI: 2754138 | tulathromycin 25 MG/ML [Macrosyn] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2754139 | Macrosyn 25 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2754139 | Macrosyn 25 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2754139 | Macrosyn 25 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2754142 | Insulin efsitora alfa | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2754142 | Insulin efsitora alfa | Designated preferred name (PT) | YES | |
| RxCUI: 2754142 | Insulin efsitora alfa | Full form of descriptor (FN) | YES | |
| RxCUI: 2754142 | Insulin efsitora alfa | Designated preferred name (PT) | YES | |
| RxCUI: 2754142 | Insulin efsitora alfa | Full form of descriptor (FN) | YES | |
| RxCUI: 2754143 | insulin efsitora alfa-gobe | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2754144 | insulin efsitora alfa-gobe 500 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2754145 | insulin efsitora alfa Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2754146 | insulin efsitora alfa Pen Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2754149 | insulin efsitora alfa-gobe 500 UNT/ML in 3 ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2754149 | insulin efsitora alfa-gobe 500 UNT/ML in 3 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754149 | insulin efsitora alfa-gobe 500 UNT/ML in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754150 | insulin efsitora alfa-gobe 500 UNT/ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2754150 | insulin efsitora alfa-gobe 500 UNT/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2754151 | Onswik | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2754152 | insulin efsitora alfa-gobe 500 UNT/ML [Onswik] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2754153 | Onswik Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2754154 | insulin efsitora alfa Pen Injector [Onswik] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2754156 | onswik 500 UNT/ML in 3 ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2754156 | onswik 500 UNT/ML in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754156 | onswik 500 UNT/ML in 3 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754156 | onswik 500 UNT/ML in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754156 | onswik 500 UNT/ML in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754157 | Onswik 500 UNT/ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2754157 | Onswik 500 UNT/ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2754157 | Onswik 500 UNT/ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2754158 | insulin efsitora alfa-gobe 1000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2754159 | insulin efsitora alfa-gobe 1000 UNT/ML in 3 ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2754159 | insulin efsitora alfa-gobe 1000 UNT/ML in 3 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754159 | insulin efsitora alfa-gobe 1000 UNT/ML in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754160 | insulin efsitora alfa-gobe 1000 UNT/ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2754160 | insulin efsitora alfa-gobe 1000 UNT/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2754161 | insulin efsitora alfa-gobe 1000 UNT/ML [Onswik] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2754162 | onswik 1000 UNT/ML in 3 ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2754162 | onswik 1000 UNT/ML in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754162 | onswik 1000 UNT/ML in 3 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754162 | onswik 1000 UNT/ML in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754162 | onswik 1000 UNT/ML in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754163 | Onswik 1000 UNT/ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2754163 | Onswik 1000 UNT/ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2754163 | Onswik 1000 UNT/ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2754164 | petrolatum 49.9 % / zinc oxide 2 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2754164 | petrolatum 49.9 % / zinc oxide 2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2754164 | petrolatum 49.9 % / zinc oxide 2 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2754164 | petrolatum 49.9 % / zinc oxide 2 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2754166 | selenium 800 MCG in 20 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2754166 | selenium 800 MCG in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754166 | selenium 800 MCG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754329 | Gobarden | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2754330 | bendamustine hydrochloride 25 MG/ML [Gobarden] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2754331 | Gobarden Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2754332 | bendamustine Injectable Solution [Gobarden] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2754334 | Gobarden 25 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2754334 | Gobarden 25 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754334 | Gobarden 25 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754335 | rocuronium bromide 100 MG in 10 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2754335 | rocuronium bromide 100 MG in 10 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754335 | rocuronium bromide 100 MG in 10 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754360 | tavapadon | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2754361 | tavapadon 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2754362 | tavapadon Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2754363 | tavapadon Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2754364 | tavapadon Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2754365 | tavapadon 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754365 | tavapadon 5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2754366 | Juvmo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2754367 | tavapadon 5 MG [Juvmo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2754368 | Juvmo Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2754369 | Juvmo Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2754370 | tavapadon Oral Tablet [Juvmo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2754371 | JUVMO 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754371 | JUVMO 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754371 | JUVMO 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2754372 | tavapadon 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2754373 | tavapadon 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754373 | tavapadon 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2754374 | tavapadon 10 MG [Juvmo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2754375 | JUVMO 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754375 | JUVMO 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754375 | JUVMO 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2754376 | tavapadon 15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2754377 | tavapadon 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754377 | tavapadon 15 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2754378 | tavapadon 15 MG [Juvmo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2754379 | JUVMO 15 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754379 | JUVMO 15 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754379 | JUVMO 15 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2754380 | tavapadon 0.25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2754381 | tavapadon 0.25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754381 | tavapadon 0.25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2754382 | tavapadon 0.25 MG [Juvmo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2754383 | JUVMO 0.25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754383 | JUVMO 0.25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754383 | JUVMO 0.25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2754384 | tavapadon 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2754385 | tavapadon 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754385 | tavapadon 1 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2754386 | tavapadon 1 MG [Juvmo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2754387 | JUVMO 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754387 | JUVMO 1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754387 | JUVMO 1 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2754388 | tavapadon 0.25 MG (36), tavapadon 1 MG (64) Oral Tablet Titration Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2754388 | tavapadon 0.25 MG (36), tavapadon 1 MG (64) Oral Tablet Titration Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754388 | tavapadon 0.25 MG (36), tavapadon 1 MG (64) Oral Tablet Titration Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754389 | JUVMO Titration Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2754389 | JUVMO Titration Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754389 | JUVMO Titration Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754390 | lidocaine 10 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2754390 | lidocaine 10 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754390 | lidocaine 10 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754391 | Bondlido | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2754392 | lidocaine 0.1 MG/MG [Bondlido] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2754393 | Bondlido Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2754394 | lidocaine Medicated Patch [Bondlido] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2754395 | BONDLIDO 10 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754395 | BONDLIDO 10 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754395 | BONDLIDO 10 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754395 | BONDLIDO 10 % Medicated Patch | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2754425 | floretyrosine F-18 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 27545 | Indolepyruvate methyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 27545 | Indolepyruvate methyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 2754645 | salicylic acid 45 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2754645 | salicylic acid 45 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2754645 | salicylic acid 45 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2754646 | zilurgisertib fumarate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2754647 | zilurgisertib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2754648 | zilurgisertib 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2754649 | zilurgisertib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2754650 | zilurgisertib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2754651 | zilurgisertib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2754652 | zilurgisertib 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754652 | zilurgisertib 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754652 | zilurgisertib 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2754653 | Atebrioz | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2754654 | zilurgisertib 25 MG [Atebrioz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2754655 | Atebrioz Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2754656 | Atebrioz Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2754657 | zilurgisertib Oral Tablet [Atebrioz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2754658 | ATEBRIOZ 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754658 | ATEBRIOZ 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754658 | ATEBRIOZ 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2754659 | Akkermansia muciniphila 1000000000 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2754660 | inulin 390 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2754661 | Akkermansia muciniphila / inulin | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2754662 | Akkermansia muciniphila / inulin Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2754663 | Akkermansia muciniphila / inulin Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2754664 | Akkermansia muciniphila / inulin Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2754665 | Akkermansia muciniphila 1 billion UNT / inulin 390 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754665 | Akkermansia muciniphila 1 billion UNT / inulin 390 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754665 | Akkermansia muciniphila 1 billion UNT / inulin 390 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2754666 | adalimumab-aqvh 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2754667 | adalimumab-aqvh 40 MG in 0.4 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2754667 | adalimumab-aqvh 40 MG in 0.4 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754667 | adalimumab-aqvh 40 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754668 | adalimumab-aqvh 100 MG/ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2754668 | adalimumab-aqvh 100 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2754669 | adalimumab-aqvh 100 MG/ML [Yusimry] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2754670 | YUSIMRY 40 MG in 0.4 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2754670 | YUSIMRY 40 MG in 0.4 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754670 | YUSIMRY 40 MG in 0.4 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754671 | YUSIMRY 100 MG/ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2754671 | YUSIMRY 100 MG/ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2754671 | YUSIMRY 100 MG/ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2754672 | adalimumab-aqvh 80 MG in 0.8 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2754672 | adalimumab-aqvh 80 MG in 0.8 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754672 | adalimumab-aqvh 80 MG in 0.8 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754673 | YUSIMRY 80 MG in 0.8 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2754673 | YUSIMRY 80 MG in 0.8 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754673 | YUSIMRY 80 MG in 0.8 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754674 | Calycophyllum multiflorum whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2754675 | arginine oleate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2754678 | cyproheptadine hydrochloride 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2754679 | cyproheptadine hydrochloride 2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754679 | cyproheptadine hydrochloride 2 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2754680 | Cyprolara | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2754681 | cyproheptadine hydrochloride 2 MG [Cyprolara] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2754682 | Cyprolara Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2754683 | Cyprolara Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2754684 | cyproheptadine Oral Tablet [Cyprolara] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2754686 | Cyprolara 2 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2754686 | Cyprolara 2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754686 | Cyprolara 2 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754762 | chlorhexidine gluconate 1.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2754763 | chlorhexidine gluconate 0.13 % Oral Rinse | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2754763 | chlorhexidine gluconate 0.13 % Oral Rinse | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2754763 | chlorhexidine gluconate 0.13 % Oral Rinse | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2754764 | Opti-Scrub | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2754765 | chloroxylenol 6 MG/ML [Opti-Scrub] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2754766 | Opti-Scrub Soap Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2754767 | chloroxylenol Medicated Liquid Soap [Opti-Scrub] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2754768 | OPTI-SCRUB 0.6 % Medicated Liquid Soap | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2754768 | OPTI-SCRUB 0.6 % Medicated Liquid Soap | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2754768 | OPTI-SCRUB 0.6 % Medicated Liquid Soap | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2754770 | glyceryl phosphate Injectable Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2754772 | sodium glycerophosphate 216 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754772 | sodium glycerophosphate 216 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754772 | sodium glycerophosphate 216 MG/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2754773 | glyceryl phosphate Injectable Solution [Glycophos] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2754775 | Glycophos 216 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754775 | Glycophos 216 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2754775 | Glycophos 216 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2754775 | Glycophos 216 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2754836 | Neosetophoma cerealis | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2754869 | Fungiflush | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2754870 | undecylenic acid 250 MG/ML [Fungiflush] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2754871 | Fungiflush Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2754872 | undecylenate Topical Solution [Fungiflush] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2754874 | FungiFlush 25 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2754874 | FungiFlush 25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2754874 | FungiFlush 25 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2754877 | polyethylene glycol 18000 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2755 | C2 - complement component 2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2755 | C2 - complement component 2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2755 | C2 - complement component 2 | Designated preferred name (PT) | NO | |
| RxCUI: 2755 | C2 - complement component 2 | Full form of descriptor (FN) | NO | |
| RxCUI: 2756 | C3 - complement component 3 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2756 | C3 - complement component 3 | Designated preferred name (PT) | NO | |
| RxCUI: 2756 | C3 - complement component 3 | Full form of descriptor (FN) | NO | |
| RxCUI: 2756 | C3 - complement component 3 | Designated preferred name (PT) | NO | |
| RxCUI: 2756 | C3 - complement component 3 | Full form of descriptor (FN) | NO | |
| RxCUI: 275635 | desloratadine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 275635 | desloratadine | Designated preferred name (PT) | YES | |
| RxCUI: 275635 | desloratadine | Full form of descriptor (FN) | YES | |
| RxCUI: 275635 | desloratadine | Designated preferred name (PT) | YES | |
| RxCUI: 275635 | desloratadine | Full form of descriptor (FN) | YES | |
| RxCUI: 27579 | Innovar | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2758 | C3 - complement component 3 nephritic factor | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2758 | C3 - complement component 3 nephritic factor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2758 | C3 - complement component 3 nephritic factor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2758 | C3 - complement component 3 nephritic factor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2758 | C3 - complement component 3 nephritic factor | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2758 | C3 - complement component 3 nephritic factor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2758 | C3 - complement component 3 nephritic factor | Designated preferred name (PT) | NO | |
| RxCUI: 2758 | C3 - complement component 3 nephritic factor | Full form of descriptor (FN) | NO | |
| RxCUI: 2758 | C3 - complement component 3 nephritic factor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 27581 | Inosamine-phosphate amidinotransferase | Designated preferred name (PT) | NO | |
| RxCUI: 27581 | Inosamine-phosphate amidinotransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 27585 | Inosinase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 27585 | Inosinase | Designated preferred name (PT) | NO | |
| RxCUI: 27585 | Inosinase | Full form of descriptor (FN) | NO | |
| RxCUI: 27586 | ITP pyrophosphohydrolase | Designated preferred name (PT) | NO | |
| RxCUI: 27586 | ITP pyrophosphohydrolase | Full form of descriptor (FN) | NO | |
| RxCUI: 27586 | ITP pyrophosphohydrolase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 275891 | valganciclovir | Full form of descriptor (FN) | YES | |
| RxCUI: 275891 | valganciclovir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 275891 | valganciclovir | Designated preferred name (PT) | YES | |
| RxCUI: 275891 | valganciclovir | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 275891 | valganciclovir | Full form of descriptor (FN) | YES | |
| RxCUI: 275891 | valganciclovir | Designated preferred name (PT) | YES | |
| RxCUI: 2759 | C3a - complement component 3a | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2759 | C3a - complement component 3a | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2759 | C3a - complement component 3a | Designated preferred name (PT) | NO | |
| RxCUI: 2759 | C3a - complement component 3a | Full form of descriptor (FN) | NO |